Skip to content

Detection of occult lymph node metastasis of laryngeal carcinoma by sentinel node biopsy

Detection of occult lymph node metastasis of laryngeal carcinoma by sentinel node biopsy - LARS-study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32214
Enrollment
20
Registered
2008-06-20
Start date
2008-06-23
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laryngeal cancer

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients scheduled for laryngectomy and (selective) neck dissection for (advanced or recurrent) laryngeal carcinoma Primary tumor accessible for peritumoral injection of radiolabeled colloid on direct laryngoscopy No lymph node metastases on CT, MRI or ultrasound guided fine needle aspiration cytology

Exclusion criteria

Exclusion criteria: Clinical lymph node metastases Tumor not accessible for endoscopic injection age > 80 jaar

Design outcomes

Primary

MeasureTime frame
Primary endpoint the feasibility and validation of sentinel node biopsy procedure in patients with (recurrences of) laryngeal carcinomas scheduled for total laryngectomy.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)